MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/20.06.25 Share Price

Warrant

DE000ME7L5J1

Market Closed - Börse Stuttgart 17:53:36 04/07/2024 BST
0.099 EUR -10.81% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/20.06.25
Current month-14.62%
1 month+11.00%
Date Price Change
04/07/24 0.099 -10.81%
03/07/24 0.111 -7.50%
02/07/24 0.12 -4.76%
01/07/24 0.126 -3.08%
28/06/24 0.13 +4.84%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 05:53 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME7L5J
ISINDE000ME7L5J1
Date issued 25/01/2024
Strike 180 $
Maturity 20/06/2025 (351 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.226
Lowest since issue 0.07
Spread 0.033
Spread %25.00%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus